| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/24/2005 | US20050064452 Sensor array apparatus comprising sensing element immobilized biopolymers for use as tool in detection of single nucleotide polymorphisms in genes; gene expression analysis |
| 03/24/2005 | US20050064451 Methods and compositions for the detection of bacterial species |
| 03/24/2005 | US20050064450 Using unique sequences, polymerase chain reaction and alcohol extraction to generate repetitive sequence removed probes (RSRP) for use in cancer detection |
| 03/24/2005 | US20050064449 Modified DNA fragment devoid of repetitive sequences for use as tool in detection of chromosomal abnormalities |
| 03/24/2005 | US20050064445 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 03/24/2005 | US20050064444 Oligonucleotide for use in simultaneous and specific detection of legionella, fecal streptococci and coliform bacteria in drinking and surface water |
| 03/24/2005 | US20050064442 Using allelic variation in breast cancer genes (BRAC1/2) as diagnostic tools in diagnosing/prognosing mammary gland cell proliferative disorders |
| 03/24/2005 | US20050064441 Utilizing predetermined sequences as quantitative tools in detection of target sequences; gene expression analysis and restriction fragment length polymorphisms; forensics |
| 03/24/2005 | US20050064440 Using single nucleotide polymorphism in contactin-2 (CNTN-2) and kinesin-7 (CENP-E) genes as diagnostic indicators of cell proliferative disorders; antitumor agents; ribozymes and tumor treatment; RNA interference |
| 03/24/2005 | US20050064437 Oligonucleotides and methods for detecting hepatitis B viral nucleic acids |
| 03/24/2005 | US20050064436 Methods and compositions for identifying patient samples |
| 03/24/2005 | US20050064435 Using biopolymers comprising modular code sections as diagnostic tool in detection of pathogens, cells and preferential biological molecules |
| 03/24/2005 | US20050064434 Offset diecut stack |
| 03/24/2005 | US20050064432 Solid support comprising promoter primer that can be extended to form a transcribable template nucleic acid; and a capture probe for use as diagnostic tool in gene expression analysis; medical diagnosis; genotyping; forensics; high throughput assay |
| 03/24/2005 | US20050064429 Using polymorphism in gene coding endothelial nitric oxide synthase (eNOS) as diagnostic indicator of renal disorder |
| 03/24/2005 | US20050064428 Using cytosine conversion to uracil as methylation diagnostic; cytosine methylation as tool in diagnosing cell proliferative, psychological, metabolic, cardiovascular and respiratory and sexual disorders |
| 03/24/2005 | US20050064426 Utilizing probe dependent coefficients to re-scale and correct hybridization data; enhancing accuracy of measured gene expression levels |
| 03/24/2005 | US20050064425 Using overlapping and non-overlapping gene expression profiles as tool in detecting transcriptional units of novel function |
| 03/24/2005 | US20050064424 Method of identifying novel proteins |
| 03/24/2005 | US20050064422 Polypeptide quantitation |
| 03/24/2005 | US20050064421 Generating microarrays comprising immobilized gene sequences from cells associated with immune response; characterizing transcription units associated stimulated lymphocytes |
| 03/24/2005 | US20050064420 Expression vector comprising nucleotide sequences coding estrogen response element for use as regulatory tool in heterologous gene expression |
| 03/24/2005 | US20050064419 Using single stranded DNA to determining variance in allelic fragments; genomic characterization |
| 03/24/2005 | US20050064417 Methods and compositions to evaluate antibody treatment response |
| 03/24/2005 | US20050064416 Methods for diagnosing and treating heart disease |
| 03/24/2005 | US20050064415 Novel terthiophene-3-carboxylic acid compound and fabricating method thereof, functionalized conductive terthiophene polymer with the compound as a monomer, process for dna hybridizatioon detection using the polymer, and fabricating method of probe dna |
| 03/24/2005 | US20050064414 DNA/RNA transcription; incubation with RNA polymerases; fluorescence resonance energy transfer; solid phase synthesis |
| 03/24/2005 | US20050064412 Using methylation profile of heparan sulfate D-glucosaminyl 3-0-sulfotransferase gene sequences as diagnostic/prognostic indicators of mamary gland cell proliferative disorders |
| 03/24/2005 | US20050064411 Diagnostic probe for identifying ubiquitin ligase (NEDl-1) profile for use as diagnostic and prognostic indicator of cell proliferative disorders of nervous system |
| 03/24/2005 | US20050064410 Method and nucleic acids for the analysis of colon cancer |
| 03/24/2005 | US20050064409 Chp for use as marker for sepsis-type inflammatory diseases |
| 03/24/2005 | US20050064408 Method for gene mapping from chromosome and phenotype data |
| 03/24/2005 | US20050064406 Methods for high throughput genome analysis using restriction site tagged microarrays |
| 03/24/2005 | US20050064404 Regulation of human serotonin-like g protein-coupled receptor |
| 03/24/2005 | US20050064403 Novel Genes Encoding Novel Proteolytic Enzymes |
| 03/24/2005 | US20050064402 Tumor marker and methods of use |
| 03/24/2005 | US20050064401 Diagnosis of illnesses or predisposition to certain illnesses |
| 03/24/2005 | US20050064400 System and method for temperature gradient capillary electrophoresis |
| 03/24/2005 | US20050064398 Primers for use in detecting beta-lactamases |
| 03/24/2005 | US20050064397 Method for mutation detection in HIV-1 using pol sequencing |
| 03/24/2005 | US20050064395 Liquid crystal based analyte detection |
| 03/24/2005 | US20050064394 Viral deletion mutant comprising nucleotide sequences associated with temperance factors for use as tool in detection of modulators which prevent and treat viral infection; viricides; genetic vaccines |
| 03/24/2005 | US20050064393 Using long terminal repeats as diagnostic indicator in detection of cells newly infected wih lymphadenopathy associated viral sequences in patients with undetectable viral loads |
| 03/24/2005 | US20050064389 Chimeric lyssavirus nucleic acids and polypeptides |
| 03/24/2005 | US20050064386 Identification of toxin-binding protein involved in resistance to Cry1 toxins, and related screening methods |
| 03/24/2005 | US20050064385 end point assay; insulin reduction in presence of dithiothreitol, aggregation measurements of reduced insulin chains, hydrogen peroxide as stop reagent; antihypoxic agents |
| 03/24/2005 | US20050064384 Using cells expressing nitric oxide reductase (NORE) and preferential kinases (MST1/2) as tools in identifying modulator for prevention and treatment of cell proliferative disorders; antitumor agents |
| 03/24/2005 | US20050064383 semen sorted by fluorescence-activated cell sorting into gender-enriched populations enriched in X-chromosome or Y-chromosome bearing sperm by use of a fluorescent quantitative DNA-binding vital staining |
| 03/24/2005 | US20050064341 Composition containing a photoacid generator monomer, substrate coated with the composition, method for synthesizing a compound on a substrate using the composition, and microarray produced according to the method |
| 03/24/2005 | US20050063985 Method and compositions for immunization with the pseudomonas v antigen |
| 03/24/2005 | US20050063974 Detecting expression of a tyrosine threonine kinase-encoding polynucleotide in order to assess prognosis of colon or breast cancer |
| 03/24/2005 | US20050063971 Monoclonal or humanized antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, polypeptide fragment, polynucleotide or antibody |
| 03/24/2005 | US20050063969 Assay |
| 03/24/2005 | US20050063942 Methods for predicting sensitivity of tumors to arginine deprivation |
| 03/24/2005 | DE10340373A1 Determining the hair cycle in humans, by measuring protein or mRNA levels and classification as anagenic or catagenic, also for screening therapeutic or cosmetic agents that affect hair growth |
| 03/24/2005 | DE10339962A1 In vitro testing of potential pharmaceutical agents, based on investigating their metabolism, or metabolic effects, in presence of free radicals |
| 03/24/2005 | DE10339927A1 Zusammensetzung zur Prophylaxe/Therapie von HBV-Infektionen und HBV-vermittelten Erkrankungen A composition for prophylaxis / therapy of HBV infection and HBV-mediated diseases |
| 03/24/2005 | DE10339609A1 Oligonukleotid, Verfahren und System zur Detektion von Antibiotikaresistenz-vermittelnden Genen in Mikroorganismen mittels der Echtzeit-PCR Oligonucleotide, method and system for the detection of antibiotic resistance-mediating genes in microorganisms by means of the real-time PCR |
| 03/24/2005 | DE10338308A1 Verfahren zum Nachweis von Cytosin-Methylierungen in DNA A method for the detection of cytosine methylations in DNA |
| 03/24/2005 | DE10253966B4 Microarray-basiertes Verfahren zur Amplifikation und Detektion von Nukleinsäuren in einem kontinuierlichen Prozess Microarray-based method for the amplification and detection of nucleic acids in a continuous process |
| 03/24/2005 | DE102004028302A1 Stimulierung der Synthese und der Aktivität einer Isoform der Lysyloxidase-ähnlichen LOXL zum Stimulieren der Bildung von elastischen Fasern Stimulation of the synthesis and the activity of one isoform of the lysyl oxidase-like LOXL for stimulating the formation of elastic fibers |
| 03/24/2005 | CA2539490A1 Differentially expressed tumour-specific polypeptides for use in the diagnosis and treatment of cancer |
| 03/24/2005 | CA2539132A1 Methods for identifying modulators of protein kinase c-epsilon (pkc.epsilon.) and method of treatment of aberrant glucose metabolism associated therewith |
| 03/24/2005 | CA2539046A1 Increasing the bioavailability of carotenoids by enzymatic hydrolysis of the corresponding fatty acid esters |
| 03/24/2005 | CA2538843A1 Animal model for protease activity and liver damage |
| 03/24/2005 | CA2538797A1 Multiplex binding and activity assays |
| 03/24/2005 | CA2538754A1 Inhibition of inward sodium currents in cancer |
| 03/24/2005 | CA2538528A1 Genetic products which are differentially expressed in tumours and use thereof |
| 03/24/2005 | CA2538514A1 Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes |
| 03/24/2005 | CA2538495A1 The use of eukaryotic genes affecting chromatin separation for diagnosis and treatment of proliferative diseases |
| 03/24/2005 | CA2538448A1 Insulin-like growth factor-1 receptor (igf-1r) polymorphic alleles and use of the same to identify dna markers for reproductive longevity |
| 03/24/2005 | CA2538442A1 Eukaryotic genes for modulating cell cycle progression |
| 03/24/2005 | CA2538440A1 Methods and device for adhesive control of internal cell organisation |
| 03/24/2005 | CA2538326A1 Apparatus and method for identifying therapeutic targets using a computer model |
| 03/24/2005 | CA2538222A1 Methods for risk assessment, survival prediction and treatment of heart failure and other conditions based on adrenergic receptor polymorphisms |
| 03/24/2005 | CA2538137A1 Method for gene identification signature (gis) analysis |
| 03/24/2005 | CA2538086A1 Assay for sars coronavirus by amplification and detection of nucleocapsid rna sequence |
| 03/24/2005 | CA2538082A1 Assay for sars coronavirus by amplification and detection of the replicase sequence |
| 03/24/2005 | CA2538069A1 Effectors of innate immunity determination |
| 03/24/2005 | CA2537429A1 Method and device for detecting feline immunodeficiency virus |
| 03/24/2005 | CA2536989A1 Lawsonia intracellularis subunit vaccine |
| 03/24/2005 | CA2536949A1 Detection of 13q14 chromosomal alterations |
| 03/24/2005 | CA2536735A1 Methods for determining cd8+ t-cell epitopes |
| 03/24/2005 | CA2503840A1 Direct detection method for products of cellular metabolism using tof-sims |
| 03/23/2005 | EP1517253A2 Method for design support of functional nucleic acids |
| 03/23/2005 | EP1517178A1 A process for preparing peptide nucleic acid probe using monomeric photoacid generator |
| 03/23/2005 | EP1517146A2 Flamingo (ant)agonists for the diagnosis and treatment of cancer |
| 03/23/2005 | EP1517144A2 Method of identifying an antibody binding to and modulating the activity of a human vanilloid receptor |
| 03/23/2005 | EP1516933A1 Stable hybrids by selecting the position of the probe relative to the target |
| 03/23/2005 | EP1516932A1 Poxvirus with targeted infection specificity |
| 03/23/2005 | EP1516665A1 A method of immobilizing and stretching a nucleic acid on a substrate |
| 03/23/2005 | EP1516274A1 Method for predicting a drug transport capability by abcg2 polymorphisms |
| 03/23/2005 | EP1516190A1 Method for identifying agonists or antagonists for the g-protein coupled mas-like 1 receptor |
| 03/23/2005 | EP1516186A1 A method for the detection of apoptosis |
| 03/23/2005 | EP1516174A1 Method and device for high sensitivity detection of the presence of dna and other probes |
| 03/23/2005 | EP1516170A1 Lysing reagent, cartridge and automatic electronic cell counter for simultaneous enumeration of different types of white blood cells |
| 03/23/2005 | EP1516067A2 Detection of toxic algae |
| 03/23/2005 | EP1516066A1 Methods for the detection of polymorphisms in the human oatpf gene |
| 03/23/2005 | EP1516065A1 Methods for detecting polymorphisms using arms or rflp |
| 03/23/2005 | EP1516063A2 Nucleotide and amino acid sequences relating to respiratory diseases and obesity |